New study indicates that even delayed treatment with oseltamivir improves survival in patients infected with avian influenza (H5N1)
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu’, even when given late in the course of illness. Read the full release.
Click on one of the links below to watch an interview with Dr. Nancy Dreyer discussing the study:
Tell us about the study:
For further information please contact:
Nancy Dreyer, MPH, PhD, Chief of Scientific Affairs and Senior Vice President, Outcome
+1 (617) 715-6810